0
Sept 28 (Reuters) – Innovent Biologics, Inc.: * JAYPIRCA (PIRTROBRUTINIB) APPROVED IN CHINA FOR CLL/SLL ACROSS ALL LINES OF THERAPY Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
